Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

A limiting factor for the use of adeno-associated viruses (AAVs) as vectors in gene therapy is the broad tropism of AAV serotypes, i.e., the parallel infection of several cell types. Nanobodies are single immunoglobulin variable domains from heavy chain antibodies that naturally occur in camelids. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichhoff, Anna Marei, Börner, Kathleen, Albrecht, Birte, Schäfer, Waldemar, Baum, Natalie, Haag, Friedrich, Körbelin, Jakob, Trepel, Martin, Braren, Ingke, Grimm, Dirk, Adriouch, Sahil, Koch-Nolte, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819893/
https://www.ncbi.nlm.nih.gov/pubmed/31687421
http://dx.doi.org/10.1016/j.omtm.2019.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819893/
https://www.ncbi.nlm.nih.gov/pubmed/31687421
http://dx.doi.org/10.1016/j.omtm.2019.09.003

Ejemplares similares